The last decade of research into the pharmacogenetics of antipsychotics has seen the
development of genetic tests to determine the patients’ metabolic status and the first attempts at …

This review presents the findings of pharmacogenetic studies exploring the influence of gene
variants on antipsychotic treatment response, in terms of both symptom improvement and …

Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting
substantial pleiotropy of contributing loci. However, the nature and mechanisms of these …

The serotonin transporter (5-HTT) is a candidate locus for aetiological involvement in
affective disorders. Biochemical studies in suicides and depressed patients suggest that 5-HT …

Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology.
Understanding the genetic factors contributing to the shared and disorder-specific symptoms …

We did association studies in multiple candidate genes to find the combination of polymorphisms
that give the best predictive value of response to clozapine in schizophrenic patients. A …

BACKGROUND: The –1438A/G single nucleotide polymorphism (SNP) lies just upstream of
two alternative promoters for the 5-hydroxytryptamine type 2A (5-HT2A) receptor gene (…

We report allelic association between a polymorphism (T102C) within the coding region of
the 5-HT 2A gene (HTR2A, 13q14-21) and response to clozapine in schizophrenic patients. …

Serotonin (5-HT) neurotransmitter receptors are targeted by atypical antipsychotic drugs.
We hypothesized that genetic variation in these receptors may affect clinical response to the …

Clozapine is a potent atypical antipsychotic which binds to a variety of neurotransmitter
receptors including serotonin (5-HT) receptors. However, the precise neurochemical site of …